Annual Gross Profit
$194.70 K
+$11.10 K+6.05%
31 August 2023
Summary:
Lexaria Bioscience annual gross profit is currently $194.70 thousand, with the most recent change of +$11.10 thousand (+6.05%) on 31 August 2023. During the last 3 years, it has fallen by -$352.70 thousand (-64.43%). LEXX annual gross profit is now -66.11% below its all-time high of $574.50 thousand, reached on 31 October 2012.LEXX Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$84.00 K
-$61.00 K-42.07%
31 May 2024
Summary:
Lexaria Bioscience quarterly gross profit is currently $84.00 thousand, with the most recent change of -$61.00 thousand (-42.07%) on 31 May 2024. Over the past year, it has increased by +$53.30 thousand (+173.62%). LEXX quarterly gross profit is now -91.81% below its all-time high of $1.03 million, reached on 31 October 2007.LEXX Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$406.20 K
+$19.00 K+4.91%
31 May 2024
Summary:
Lexaria Bioscience TTM gross profit is currently $406.20 thousand, with the most recent change of +$19.00 thousand (+4.91%) on 31 May 2024. Over the past year, it has increased by +$211.50 thousand (+108.63%). LEXX TTM gross profit is now -66.99% below its all-time high of $1.23 million, reached on 31 July 2008.LEXX TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LEXX Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +173.6% | +108.6% |
| 3 y3 years | -64.4% | +685.0% | -25.8% |
| 5 y5 years | -2.5% | -23.8% | +103.3% |
LEXX Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -64.4% | +6.0% | -42.7% | +912.0% | -25.8% | +226.5% |
| 5 y | 5 years | -64.4% | +6.0% | -63.7% | +507.8% | -30.9% | +730.7% |
| alltime | all time | -66.1% | +254.0% | -91.8% | +113.1% | -67.0% | +145.3% |
Lexaria Bioscience Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2024 | - | $84.00 K(-42.1%) | $406.20 K(+4.9%) |
| Feb 2024 | - | $145.00 K(-1.0%) | $387.20 K(+49.3%) |
| Nov 2023 | - | $146.50 K(+377.2%) | $259.30 K(+33.2%) |
| Aug 2023 | $194.70 K(+6.0%) | $30.70 K(-52.8%) | $194.70 K(-16.8%) |
| May 2023 | - | $65.00 K(+280.1%) | $233.90 K(-6.4%) |
| Feb 2023 | - | $17.10 K(-79.1%) | $250.00 K(-2.8%) |
| Nov 2022 | - | $81.90 K(+17.2%) | $257.20 K(+40.1%) |
| Aug 2022 | $183.60 K(-66.5%) | $69.90 K(-13.8%) | $183.60 K(+47.6%) |
| May 2022 | - | $81.10 K(+233.7%) | $124.40 K(-33.6%) |
| Feb 2022 | - | $24.30 K(+192.8%) | $187.40 K(-42.2%) |
| Nov 2021 | - | $8300.00(-22.4%) | $324.50 K(-40.7%) |
| Aug 2021 | $547.40 K(+154.1%) | $10.70 K(-92.6%) | $547.40 K(-6.8%) |
| May 2021 | - | $144.10 K(-10.7%) | $587.60 K(+27.9%) |
| Feb 2021 | - | $161.40 K(-30.2%) | $459.60 K(+65.6%) |
| Nov 2020 | - | $231.20 K(+354.2%) | $277.60 K(+467.7%) |
| Aug 2020 | $215.40 K(+7.9%) | $50.90 K(+216.1%) | $48.90 K(-54.8%) |
| May 2020 | - | $16.10 K(-178.2%) | $108.20 K(-27.3%) |
| Feb 2020 | - | -$20.60 K(-924.0%) | $148.90 K(-18.3%) |
| Nov 2019 | - | $2500.00(-97.7%) | $182.20 K(-8.8%) |
| Aug 2019 | $199.70 K(-51.1%) | $110.20 K(+94.0%) | $199.80 K(+9.2%) |
| May 2019 | - | $56.80 K(+347.2%) | $183.00 K(-30.7%) |
| Feb 2019 | - | $12.70 K(-36.8%) | $264.10 K(-35.5%) |
| Nov 2018 | - | $20.10 K(-78.5%) | $409.60 K(+0.4%) |
| Aug 2018 | $408.10 K(+1103.8%) | $93.40 K(-32.3%) | $408.00 K(+26.6%) |
| May 2018 | - | $137.90 K(-12.8%) | $322.40 K(+57.6%) |
| Feb 2018 | - | $158.20 K(+755.1%) | $204.60 K(+363.9%) |
| Nov 2017 | - | $18.50 K(+137.2%) | $44.10 K(+30.1%) |
| Aug 2017 | $33.90 K(-791.8%) | $7800.00(-61.2%) | $33.90 K(+5.9%) |
| May 2017 | - | $20.10 K(-973.9%) | $32.00 K(+263.6%) |
| Feb 2017 | - | -$2300.00(-127.7%) | $8800.00(+25.7%) |
| Nov 2016 | - | $8300.00(+40.7%) | $7000.00(-242.9%) |
| Aug 2016 | -$4900.00(-67.8%) | $5900.00(-290.3%) | -$4900.00(-79.8%) |
| May 2016 | - | -$3100.00(-24.4%) | -$24.30 K(+2.5%) |
| Feb 2016 | - | -$4100.00(+13.9%) | -$23.70 K(+26.1%) |
| Nov 2015 | - | -$3600.00(-73.3%) | -$18.80 K(+23.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Aug 2015 | -$15.20 K(<-9900.0%) | -$13.50 K(+440.0%) | -$15.20 K(-129.2%) |
| May 2015 | - | -$2500.00(-412.5%) | $52.10 K(-53.5%) |
| Feb 2015 | - | $800.00(-98.5%) | $112.10 K(-175.7%) |
| Aug 2014 | $0.00(0.0%) | - | - |
| July 2014 | - | $53.80 K(-6.4%) | -$148.10 K(+17.8%) |
| Apr 2014 | - | $57.50 K(+72.2%) | -$125.70 K(+32.5%) |
| Jan 2014 | - | $33.40 K(-111.4%) | -$94.90 K(<-9900.0%) |
| Oct 2013 | $0.00(-100.0%) | -$292.80 K(-484.3%) | $0.00(-100.0%) |
| July 2013 | - | $76.20 K(-13.7%) | $496.30 K(-27.6%) |
| Apr 2013 | - | $88.30 K(-31.2%) | $685.20 K(+14.5%) |
| Jan 2013 | - | $128.30 K(-37.0%) | $598.60 K(+4.2%) |
| Oct 2012 | $574.50 K(+23.3%) | $203.50 K(-23.2%) | $574.50 K(+7.2%) |
| July 2012 | - | $265.10 K(>+9900.0%) | $535.70 K(+20.4%) |
| Apr 2012 | - | $1700.00(-98.4%) | $445.00 K(-14.3%) |
| Jan 2012 | - | $104.20 K(-36.7%) | $519.10 K(+11.4%) |
| Oct 2011 | $465.90 K(+424.1%) | $164.70 K(-5.6%) | $465.90 K(+30.3%) |
| July 2011 | - | $174.40 K(+130.1%) | $357.60 K(+60.6%) |
| Apr 2011 | - | $75.80 K(+48.6%) | $222.70 K(+61.0%) |
| Jan 2011 | - | $51.00 K(-9.6%) | $138.30 K(+55.7%) |
| Oct 2010 | $88.90 K(-170.3%) | $56.40 K(+42.8%) | $88.80 K(+2120.0%) |
| July 2010 | - | $39.50 K(-559.3%) | $4000.00(-116.4%) |
| Apr 2010 | - | -$8600.00(-673.3%) | -$24.40 K(-64.6%) |
| Jan 2010 | - | $1500.00(-105.3%) | -$69.00 K(-45.4%) |
| Oct 2009 | -$126.40 K(+953.3%) | -$28.40 K(-355.9%) | -$126.40 K(-59.8%) |
| July 2009 | - | $11.10 K(-120.9%) | -$314.60 K(+34.0%) |
| Apr 2009 | - | -$53.20 K(-4.8%) | -$234.80 K(+44.0%) |
| Jan 2009 | - | -$55.90 K(-74.2%) | -$163.10 K(+1270.6%) |
| Oct 2008 | -$12.00 K(-109.4%) | -$216.60 K(-338.3%) | -$11.90 K(-101.0%) |
| July 2008 | - | $90.90 K(+391.4%) | $1.23 M(+146.0%) |
| Apr 2008 | - | $18.50 K(-80.6%) | $500.20 K(+14.6%) |
| Jan 2008 | - | $95.30 K(-90.7%) | $436.30 K(+240.3%) |
| Oct 2007 | $128.20 K(-275.6%) | $1.03 M(-260.4%) | $128.20 K(-114.3%) |
| July 2007 | - | -$639.40 K(+1308.4%) | -$897.60 K(+247.6%) |
| Apr 2007 | - | -$45.40 K(-78.7%) | -$258.20 K(+21.3%) |
| Jan 2007 | - | -$212.80 K | -$212.80 K |
| Oct 2006 | -$73.00 K | - | - |
FAQ
- What is Lexaria Bioscience annual gross profit?
- What is the all time high annual gross profit for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly gross profit?
- What is the all time high quarterly gross profit for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly gross profit year-on-year change?
- What is Lexaria Bioscience TTM gross profit?
- What is the all time high TTM gross profit for Lexaria Bioscience?
- What is Lexaria Bioscience TTM gross profit year-on-year change?
What is Lexaria Bioscience annual gross profit?
The current annual gross profit of LEXX is $194.70 K
What is the all time high annual gross profit for Lexaria Bioscience?
Lexaria Bioscience all-time high annual gross profit is $574.50 K
What is Lexaria Bioscience quarterly gross profit?
The current quarterly gross profit of LEXX is $84.00 K
What is the all time high quarterly gross profit for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly gross profit is $1.03 M
What is Lexaria Bioscience quarterly gross profit year-on-year change?
Over the past year, LEXX quarterly gross profit has changed by +$53.30 K (+173.62%)
What is Lexaria Bioscience TTM gross profit?
The current TTM gross profit of LEXX is $406.20 K
What is the all time high TTM gross profit for Lexaria Bioscience?
Lexaria Bioscience all-time high TTM gross profit is $1.23 M
What is Lexaria Bioscience TTM gross profit year-on-year change?
Over the past year, LEXX TTM gross profit has changed by +$211.50 K (+108.63%)